Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Rosenberg

Pediatric Pulmonology Tampa, FL Medical Doctor

NPI 1629033253 CMS profile 345330

4714 N Armenia Ave, Suite 201, Tampa, FL 33603

Open in the dashboard

General payments

$21,034

968 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$26,903 paid to institutions, not to them · program year 2022

Through program year 2025, David Rosenberg of Tampa, FL is reported in the CMS Open Payments database as having received $21,034 across 968 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $26,903 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Pediatric Pulmonology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,326 122
2024 General $2,475 97
2023 General $3,271 136
2022 General $3,050 144
2021 General $3,531 189
2020 General $2,661 128
2019 General $2,720 152

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Rosenberg
  • Pediatric Pulmonology median
  • Middle half of Pediatric Pulmonology
  • National median

In program year 2025, general payments to David Rosenberg were reported at $3,326. Among 622 Pediatric Pulmonology profiles paid that year, the median was $139 and the middle half received between $60 and $405.

Show as a table
Year David Rosenberg Pediatric Pulmonology median Middle half National median
2019 $2,720 $151 $59–$495 $163
2020 $2,661 $107 $34–$339 $114
2021 $3,531 $125 $40–$511 $132
2022 $3,050 $133 $49–$428 $149
2023 $3,271 $138 $44–$494 $160
2024 $2,475 $132 $46–$398 $164
2025 $3,326 $139 $60–$405 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AstraZeneca Pharmaceuticals LP $3,543 141 payments
  2. Genzyme Corporation $1,906 66 payments
  3. GlaxoSmithKline, LLC. $1,832 111 payments
  4. Sobi, Inc $1,663 73 payments
  5. Regeneron Healthcare Solutions, Inc. $1,489 62 payments
  6. Genentech USA, Inc. $1,351 64 payments
  7. Amgen Inc. $1,086 58 payments
  8. Novartis Pharmaceuticals Corporation $956 40 payments
  9. Baxter Healthcare $910 47 payments
  10. Covis Pharma B.V. $908 34 payments
  11. Other $5,390 272 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $20,707 954 payments
  2. Education $327 14 payments
Products named General payments · program years 2019–2025
  1. DUPIXENT Immunology $1,860 67 payments
  2. SYNAGIS $1,663 73 payments
  3. NUCALA $1,555 87 payments
  4. Xolair $1,137 51 payments
  5. TEZSPIRE Respiratory $1,096 38 payments
  6. FASENRA $1,006 42 payments
  7. TEZSPIRE Inflammation $980 51 payments
  8. DUPIXENT Inflammation And Immunology $980 49 payments
  9. Hillrom - Vest System Model 105 Home Care $910 47 payments
  10. ALVESCO $908 34 payments
  11. Other $9,401 456 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

968 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Pulmonology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record